Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is 8.66% vs -28.68% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -2.84% vs 5.21% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -32.40% vs -2.56% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is 33.33% vs 200.00% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Shijiazhuang Yiling Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is 8.66% vs -28.68% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 3.78% vs -1.29% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -2.84% vs 5.21% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 1,372.89% vs -85.09% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -32.40% vs -2.56% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 111.45% vs -33.25% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 33.33% vs 200.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -95.24% vs -16.83% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






